KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

17.30

+1.07 (6.59%)

At close: Mar 9, 2026, 4:00 PM EDT

17.31

+0.01 (0.08%)

After-hours: Mar 9, 2026, 7:19 PM EDT

KalVista Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 9, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2020 - 2016
Market Capitalization	874	685	479	291	312	607	Upgrade
Market Cap Growth	66.31%	42.97%	64.29%	-6.71%	-48.53%	211.76%	Upgrade
Enterprise Value	821	538	411	128	126	558	Upgrade
Last Close Price	17.30	13.77	11.35	8.53	12.73	24.97	Upgrade
PS Ratio	613.22	-	-	-	-	-	Upgrade
PB Ratio	21.35	7.18	2.32	1.81	1.69	2.36	Upgrade
P/TBV Ratio	21.44	7.18	2.32	1.81	1.69	2.36	Upgrade
EV/Sales Ratio	576.05	-	-	-	-	-	Upgrade
Debt / Equity Ratio	3.40	1.18	0.04	0.05	0.04	0.02	Upgrade
Net Debt / Equity Ratio	-1.30	-1.14	-0.98	-0.88	-0.85	-0.94	Upgrade
Net Debt / EBITDA Ratio	0.26	0.58	1.45	1.28	1.65	4.24	Upgrade
Net Debt / FCF Ratio	0.32	0.71	2.28	1.85	2.00	8.03	Upgrade
Asset Turnover	0.01	-	-	-	-	-	Upgrade
Quick Ratio	5.16	5.22	9.70	11.18	15.81	26.67	Upgrade
Current Ratio	5.37	5.35	9.90	11.46	16.73	27.04	Upgrade
Return on Equity (ROE)	-190.18%	-121.50%	-68.90%	-53.69%	-37.23%	-27.13%	Upgrade
Return on Assets (ROA)	-60.98%	-48.34%	-41.94%	-35.80%	-25.38%	-19.86%	Upgrade
Return on Capital Employed (ROCE)	-114.50%	-91.40%	-66.10%	-65.90%	-50.20%	-22.10%	Upgrade
Earnings Yield	-23.23%	-26.80%	-26.45%	-31.88%	-26.35%	-7.62%	Upgrade
FCF Yield	-19.20%	-22.40%	-18.64%	-26.23%	-25.31%	-4.98%	Upgrade
Buyback Yield / Dilution	-29.51%	-34.98%	-31.89%	-13.96%	-28.17%	-7.58%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.